Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/11297
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPetrou, S-
dc.contributor.authorRivero-Arias, O-
dc.contributor.authorDakin, H-
dc.contributor.authorLongworth, L-
dc.contributor.authorOppe, M-
dc.contributor.authorFroud, R-
dc.contributor.authorGray, A-
dc.date.accessioned2015-09-01T13:11:39Z-
dc.date.available2015-09-01T13:11:39Z-
dc.date.issued2015-08-01-
dc.identifier.citationPetrou, S. et al. (2015) ' Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement', PharmacoEconomics, 33 (10), pp. 985 - 991. doi: 10.1007/s40273-015-0319-2.en_US
dc.identifier.issn1170-7690-
dc.identifier.issn1179-2027-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/11297-
dc.descriptionThis article is a joint publication by Applied Health Economics and Health Policy, Health and Quality of Life Outcomes, International Journal of Technology Assessment in Health Care, Journal of Medical Economics, Medical Decision Making, Pharmacoeconomics, and Quality of Life Research.-
dc.description.abstract‘Mapping’ onto generic preference-based outcome measures is increasingly being used as a means of generating health utilities for use within health economic evaluations. Despite the publication of technical guides for the conduct of mapping research, guidance for the reporting of mapping studies is currently lacking. The MAPS (MApping onto Preference-based measures reporting Standards) statement is a new checklist, which aims to promote complete and transparent reporting of mapping studies. The primary audiences for the MAPS statement are researchers reporting mapping studies, the funders of the research, and peer reviewers and editors involved in assessing mapping studies for publication. A de novo list of 29 candidate reporting items and accompanying explanations was created by a working group comprising six health economists and one Delphi methodologist. Following a two-round modified Delphi survey with representatives from academia, consultancy, health technology assessment agencies and the biomedical journal editorial community, a final set of 23 items deemed essential for transparent reporting, and accompanying explanations, was developed. The items are contained in a user-friendly 23-item checklist. They are presented numerically and categorised within six sections, namely: (1) title and abstract; (2) introduction; (3) methods; (4) results; (5) discussion; and (6) other. The MAPS statement is best applied in conjunction with the accompanying MAPS explanation and elaboration document. It is anticipated that the MAPS statement will improve the clarity, transparency and completeness of reporting of mapping studies. To facilitate dissemination and uptake, the MAPS statement is being co-published by seven health economics and quality-of-life journals, and broader endorsement is encouraged. The MAPS working group plans to assess the need for an update of the reporting checklist in 5 years’ time.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rightsCopyright © The Author(s) 2015.. Rights and permissions: Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.subjectmappingen_US
dc.subjectMAPS statementen_US
dc.subjecthealth utility-
dc.subjecthealth economic evaluation-
dc.subjectDelphi survey-
dc.subjectDelphi panel-
dc.subjecttransparent reporting-
dc.titlePreferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statementen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1007/s40273-015-0319-2-
dc.relation.isPartOfPharmacoEconomics-
pubs.issue10-
pubs.publication-statusPublished-
pubs.publication-statusPublished-
pubs.volume33-
dc.rights.licensehttps://creativecommons.org/licenses/by-nc/4.0/leglacode.en-
dc.rights.holderThe Author(s)-
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdfCopyright © The Author(s) 2015.. Rights and permissions: Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.438.5 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons